Drug details

Edarbi (azilsartan medoxomil)

type of Angiotensin Receptor Blockers (ARBs)

Edarbi (azilsartan medoxomil) is an antihypertensive drug indicated for the treatment of hypertension. If blood pressure is not controlled with Edarbi alone, additional blood pressure reduction can be achieved by taking Edarbi with other antihypertensive agents.

This drug may have the following side effects:

• shortness of breath,
• little or no urination,
• painful or difficult urination,
• feeling tired,
• lightheadedness, and
• swelling in your feet or ankles

The following drugs are related to Edarbi, either as a replacement or used together:

• A-Methapred (methylprednisolone sodium succinate)
• Afeditab CR (nifedipine extended-release tablets)
• Exforge (amlodipine and valsartan)
• Norvasc (amlodipine besylate)
• Lotrel (amlodipine besylate and benazepril hcl)
• Caduet (amlodipine besylate, atorvastatin calcium)
• Atacand (candesartan cilexetil)
• Edarbyclor (azilsartan medoxomil and chlorthalidone tablets)
• Zebeta (bisoprolol fumarate)
• Bumex (bumetanide)
• Cardura (doxazosin mesylate)
• Cardura XL (doxazosin mesylate extended release tablets)
• Coreg (carvedilol)
• Coreg CR (carvedilol phosphate extended-release)
• Corgard (nadolol)
• Taztia XT (diltiazem hydrochloride extended release tablets)
• Lasix (furosemide)
• Furosemide (furosemide tablets)